These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33068303)

  • 21. Integration of personalized drug delivery systems into digital health.
    Raijada D; Wac K; Greisen E; Rantanen J; Genina N
    Adv Drug Deliv Rev; 2021 Sep; 176():113857. PubMed ID: 34389172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision Dosing: A Clinical and Public Health Imperative.
    Maxfield K; Zineh I
    JAMA; 2021 Apr; 325(15):1505-1506. PubMed ID: 33760028
    [No Abstract]   [Full Text] [Related]  

  • 23. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of microdose phenotyping to individualise dosing of patients.
    Hohmann N; Haefeli WE; Mikus G
    Clin Pharmacokinet; 2015 Sep; 54(9):893-900. PubMed ID: 25925712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient.
    Peck RW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():105-122. PubMed ID: 28961067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of challenges and opportunities in drug delivery and pharmaceutics.
    Panicucci R; Sanchez-Felix M
    Ther Deliv; 2015; 6(8):911-4. PubMed ID: 26305510
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics.
    Howard M; Barber J; Alizai N; Rostami-Hodjegan A
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1315-1330. PubMed ID: 30465453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.
    Darwich AS; Ogungbenro K; Vinks AA; Powell JR; Reny JL; Marsousi N; Daali Y; Fairman D; Cook J; Lesko LJ; McCune JS; Knibbe C; de Wildt SN; Leeder JS; Neely M; Zuppa AF; Vicini P; Aarons L; Johnson TN; Boiani J; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2017 May; 101(5):646-656. PubMed ID: 28182269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities.
    Keizer RJ; Ter Heine R; Frymoyer A; Lesko LJ; Mangat R; Goswami S
    CPT Pharmacometrics Syst Pharmacol; 2018 Dec; 7(12):785-787. PubMed ID: 30255663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The controversies surrounding polypharmacy in old age - where are we?
    Johnell K
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):825-827. PubMed ID: 30092160
    [No Abstract]   [Full Text] [Related]  

  • 32. Right Dose, Right Now: Customized Drug Dosing in the Critically Ill.
    Roberts JA; Kumar A; Lipman J
    Crit Care Med; 2017 Feb; 45(2):331-336. PubMed ID: 28098629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.
    Galetin A; Zhao P; Huang SM
    J Pharm Sci; 2017 Sep; 106(9):2204-2208. PubMed ID: 28390843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare.
    Carrera P; IJzerman MJ
    Expert Rev Pharmacoecon Outcomes Res; 2016 Aug; 16(4):435-7. PubMed ID: 27118144
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population.
    Uppugunduri CR; Ansari M
    Drug Metab Lett; 2016; 10(2):72-4. PubMed ID: 26908134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Printed Drug-Delivery Systems for Improved Patient Treatment.
    Sandler N; Preis M
    Trends Pharmacol Sci; 2016 Dec; 37(12):1070-1080. PubMed ID: 27992318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities.
    Beckmann JS; Lew D
    Genome Med; 2016 Dec; 8(1):134. PubMed ID: 27993174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model-Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing.
    Ribba B; Dudal S; Lavé T; Peck RW
    Clin Pharmacol Ther; 2020 Apr; 107(4):853-857. PubMed ID: 31955414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
    Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
    J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.